Covered recipient · General Payments record
KALLE KANG
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$6,890.88
- Reported across 273 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $503.37 | 23 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $218.14 | 10 |
| PFIZER INC. | $95.99 | 3 |
| AIMMUNE THERAPEUTICS, INC. | $53.35 | 3 |
| Gilead Sciences, Inc. | $36.20 | 2 |
| Merck Sharp & Dohme Corporation | $34.23 | 1 |
| Phathom Pharmaceuticals, Inc. | $28.26 | 2 |
| Celgene Corporation | $22.67 | 1 |
| INTERCEPT PHARMACEUTICALS, INC. | $14.53 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (23)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $13.03 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104027639 | CMS |
| ABBVIE INC. | $33.01 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104027641 | CMS |
| ABBVIE INC. | $30.80 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104027643 | CMS |
| ABBVIE INC. | $32.53 | 05/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104027645 | CMS |
| ABBVIE INC. | $23.72 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104027647 | CMS |
| ABBVIE INC. | $33.15 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104027649 | CMS |
| ABBVIE INC. | $6.57 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104027651 | CMS |
| ABBVIE INC. | $4.88 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104027653 | CMS |
| ABBVIE INC. | $8.74 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104027655 | CMS |
| ABBVIE INC. | $31.71 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104027657 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $14.50 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147022886 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $19.82 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147022900 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $19.03 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146984989 | CMS |
| Celgene Corporation | $22.67 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101140408 | CMS |
| Gilead Sciences, Inc. | $21.08 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133793061 | CMS |
| Gilead Sciences, Inc. | $15.12 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133793063 | CMS |
| Intercept Pharmaceuticals, Inc. | $14.53 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113636374 | CMS |
| Merck Sharp & Dohme LLC | $34.23 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141591108 | CMS |
| PFIZER INC. | $37.84 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131691142 | CMS |
| PFIZER INC. | $33.08 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131585797 | CMS |
| PFIZER INC. | $25.07 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131850951 | CMS |
| Phathom Pharmaceuticals, Inc. | $13.19 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151079408 | CMS |
| Phathom Pharmaceuticals, Inc. | $15.07 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151079410 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.